Predicted Trait | |
Reported Trait | Type 2 diabetes (T2D) |
Mapped Trait(s) | type 2 diabetes mellitus (MONDO_0005148) |
Score Construction | |
PGS Name | PRS424_T2D |
Development Method | |
Name | Genome-wide significant SNPs |
Parameters | NR |
Variants | |
Original Genome Build | NR |
Number of Variants | 424 |
Effect Weight Type | beta |
PGS Source | |
PGS Catalog Publication (PGP) ID | PGP000580 |
Citation (link to publication) | Zhuang P et al. Diabetes Care (2021) |
Ancestry Distribution | |
Source of Variant Associations (GWAS) | European: 100% 1,114,458 individuals (100%) |
PGS Evaluation |
Study Identifiers | Sample Numbers | Sample Ancestry | Cohort(s) |
---|---|---|---|
GWAS Catalog: GCST010555 Europe PMC: 32541925 |
1,114,458 individuals | European | 6 cohorts
|
PGS Performance Metric ID (PPM) |
PGS Sample Set ID (PSS) |
Performance Source | Trait |
PGS Effect Sizes (per SD change) |
Classification Metrics | Other Metrics | Covariates Included in the Model |
PGS Performance: Other Relevant Information |
---|---|---|---|---|---|---|---|---|
PPM020759 | PSS011395| European Ancestry| 357,419 individuals |
PGP000580 | Zhuang P et al. Diabetes Care (2021) |
Reported Trait: Type 2 diabetes | HR: 1.54 [1.5, 1.58] β: 0.431 (0.014) |
— | — | Age, sex, center, BMI, education, Townsend deprivation index, household income, smoking, alcohol consumption, physical activity, history of hypertension, history of high cholesterol, vitamin supplement use, mineral supplement use, aspirin use, and lipid-lowering medication | — |
PPM020760 | PSS011395| European Ancestry| 357,419 individuals |
PGP000580 | Zhuang P et al. Diabetes Care (2021) |
Reported Trait: HbA1c | β: 0.544 (0.007) | — | — | Age, sex, center, BMI, education, Townsend deprivation index, household income, smoking, alcohol consumption, physical activity, history of hypertension, history of high cholesterol, vitamin supplement use, mineral supplement use, aspirin use, and lipid-lowering medication | — |
PPM020779 | PSS011407| Multi-ancestry (including European)| 59,325 individuals |
PGP000587 | Luo M et al. Br J Sports Med (2023) |Ext. |
Reported Trait: Incident type 2 diabetes | — | — | Hazard ratio (HR, high vs low PRS tertile): 2.43 [2.04, 2.9] | Age as the underlying timescale, gender, genotyping array, the first 10 principal components of ancestry, ethnicity, educational attainment, household income, Townsend deprivation index, employment status, assessment center, moking status, alcohol consumption, healthy diet score, hypertension, dyslipidemia, depression, total wear time, seasonality, and total volume of physical activity | — |
PPM021336 | PSS011692| European Ancestry| 433,150 individuals |
PGP000634 | Chen JX et al. J Clin Endocrinol Metab (2023) |Ext. |
Reported Trait: Age at onset of type 2 diabetes ≤ 50 years | HR: 1.26 [1.13, 1.41] | — | — | Sex, ethnicity, education, Townsend deprivation index, 4 age groups, follow-up time category, HbA1c, BMI, systolic blood pressure, smoking status, physical activity, diet, use of antihypertensive drugs, use of lipid-lowering drugs, cardiovascular disease, parental history of diabetes | — |
PGS Sample Set ID (PSS) |
Phenotype Definitions and Methods | Participant Follow-up Time | Sample Numbers | Age of Study Participants | Sample Ancestry | Additional Ancestry Description | Cohort(s) | Additional Sample/Cohort Information |
---|---|---|---|---|---|---|---|---|
PSS011407 | — | Mean = 6.8 years IQR = [6.3, 7.3] years |
[ ,
44.0 % Male samples |
Mean = 61.1 years Sd = 7.8 years |
European, Not reported | White European (97.1%) | UKB | — |
PSS011692 | ICD-10 code, E11 | — | 433,150 individuals | — | European (British) |
— | UKB | — |
PSS011395 | — | Mean = 8.1 years | 357,419 individuals | — | European (White British) |
— | UKB | — |